← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Molecular Neurodegeneration (ISSN 1750-1326) is an open-access journal published by Springer Nature in the United Kingdom. It covers Biochemistry, Genetics and Molecular Biology, Medicine and Neuroscience. It is indexed in Scopus, Web of Science, PubMed, DOAJ and HEC. Recorded metrics: impact factor 19.6, Scopus Q1, Web of Science Q1, CiteScore 25.1 and HEC W-Category. Article processing charge: USD 3,190.

Journal title

Molecular Neurodegeneration

About the journal
Molecular Neurodegeneration is a fully open-access journal published by BMC (United Kingdom). It has published all content under an open licence (CC BY, CC0) since 2006. Topics: neurodegenerative diseases, prion diseases, dementia, ageing.
ISSN
1750-1326
Publisher
Springer Nature
Country
United Kingdom
Subject area
BiochemistryGenetics and Molecular BiologyMedicineNeuroscienceCellular and Molecular NeuroscienceMolecular BiologyNeurology (clinical)
SJR
6.262
Indexed
ScopusWeb of SciencePubMedDOAJHEC
Open access
Yes
APC (USD)
3190
SCImago Ranking
196
HEC
W-Category
Journal Website
molecularneurodegeneration.biomedcentral.com/ ↗
Registered In
2006
Instructions for Authors URL
molecularneurodegeneration.biomedcentral.com/submission-guidelines ↗
Average Time To Publication After Submission (In Weeks)
12
APC Information URL
link.springer.com/journal/13024/how-to-publish-with-us#Fees%20and%20funding ↗
Impact Factor
19.6
Waiver policy
Yes
WoS Status
Science Citation Index Expanded (SCIE)
Scopus URL
www.scopus.com/sourceid/5700191214 ↗
Has any other fees
No
Scopus Cite Score
25.1
Aims and Scope
—
Scopus Quartile
Q1
WoS Quartile
Q1

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Browse similar journals

Find Journal